Halozyme Therapeutics, Inc. · NASDAQ:HALO
Connaughton Bernadette sold 1,625 Halozyme Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, Connaughton Bernadette (Director) sold 1,625 Halozyme Therapeutics, Inc. shares at US$63.48 for US$103K under a trading plan, leaving 38,498 shares. Filed May 5, 2026 (Form 4).
- Sold
- 1,625 shares
- Price
- US$63.48
- Value
- US$103K
- Holding after
- 38,498 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Sale | 1,625 | US$63.48 | 38,498 | Direct |
Source
Related
- Halozyme Therapeutics, Inc.
- Connaughton Bernadette
- Halozyme Therapeutics, Inc. shareholders
- Form 4/A · Connaughton Bernadette · Oct 8, 2026
- Form 4 · Connaughton Bernadette · Aug 11, 2026
- Form 4 · Connaughton Bernadette · Jul 2, 2026
- Form 4 · Connaughton Bernadette · Jun 2, 2026
- Form 4 · Connaughton Bernadette · May 7, 2026
- Form 4 · Torley Helen · Oct 8, 2026
- Form 4 · Posard Matthew L. · Oct 2, 2026
- Form 4 · Daly James M · Oct 2, 2026
- Form 4 · Posard Matthew L. · Sep 17, 2026
- Form 4 · Torley Helen · Sep 11, 2026